NHS Swale CCG Community Adult Anti-Coagulation Service

Tender description

The aim of this service is for a lead provider to deliver Swale CCG's primary monitoring, dosing and prescribing service for patients aged 18 or over, mobile or housebound, who require warfarin anticoagulation management and are registered with a Swale CCG GP practice, in line with National Guidance. The service will have equitable access and will ensure that patients are treated with dignity and respect, are fully informed about their care and are able to make decisions about their care in partnership with healthcare professionals. The service will aim to provide patients with care close to home, preferably within their own GP surgery. The overarching aims of this monitoring service are: • To provide standardised and clinically effective anticoagulation management to patients receiving warfarin therapy whilst minimising the risks associated with anticoagulation • To offer transfer of care from hospital to primary care clinics for appropriate patients that have received initiated loading doses and have a reading within range as per the NPSA guidance • To produce optimum management of INR control using near patient testing. • Continue to educate patients in understanding their treatment, in terms of their condition requiring warfarin, target range for INR, the effects of over and under anticoagulation, diet, lifestyle and drug interactions • To appropriately manage patients who are over anti-coagulated, and assist GP to refer to specialist services where appropriate • To maintain a register of all patients receiving warfarin and have a treatment plan for each patient that is reviewed on a regular basis • To review the need for continuation of therapy • To identify and manage appropriately patients with specific needs i.e. poor compliance, unstable INR control or frequent non attendees • To optimise care to patients receiving warfarin therapy in terms of accessibility, continuity and waiting times, including home visiting as required by patient need. • To ensure complete and accurate documentation of the clinic process and ensuring a full record of each patient's medication and treatment plan is stored both on the patient's GP record and the dispensing pharmacy of the patient's choice. • To provide each patient with a yellow book to keep a record of all anti-coagulation therapy results and dosages. • Ensure the NPSA safety alert 18 (Actions that can make anticoagulation therapy safer) March 2007 is implemented by the provider Due to the introduction and increased uptake of NOACs the value of the contract may depreciate over the life of the contract. The contract value stated is based on the ultimate contract term of five years consisting of an initial 36 months with the option to extend by one 24 month increment to a total contract length of 60 months.